137 related articles for article (PubMed ID: 20400218)
1. The role of the renin-angiotensin system in the regulation of erythropoiesis.
Vlahakos DV; Marathias KP; Madias NE
Am J Kidney Dis; 2010 Sep; 56(3):558-65. PubMed ID: 20400218
[TBL] [Abstract][Full Text] [Related]
2. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
3. Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor.
Kato H; Ishida J; Imagawa S; Saito T; Suzuki N; Matsuoka T; Sugaya T; Tanimoto K; Yokoo T; Ohneda O; Sugiyama F; Yagami K; Fujita T; Yamamoto M; Nangaku M; Fukamizu A
FASEB J; 2005 Dec; 19(14):2023-5. PubMed ID: 16223784
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
6. [Role of renin-angiotensin system in prostate cancer].
Uemura H; Kubota Y
Gan To Kagaku Ryoho; 2009 Aug; 36(8):1228-33. PubMed ID: 19692759
[TBL] [Abstract][Full Text] [Related]
7. How to explain the differences between renin angiotensin system modulators.
Levy BI
Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
[TBL] [Abstract][Full Text] [Related]
8. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients.
Hirakata H; Onoyama K; Hori K; Fujishima M
Clin Nephrol; 1986 Jul; 26(1):27-32. PubMed ID: 3524928
[TBL] [Abstract][Full Text] [Related]
9. The problem of obesity: is there a role for antagonists of the renin-angiotensin system?
Weisinger RS; Begg DP; Chen N; Jois M; Mathai ML; Sinclair AJ
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():359-67. PubMed ID: 17392133
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.
Abdelrahman AM; Burrell LM; Johnston CI
J Hypertens Suppl; 1993 Apr; 11(3):S23-6. PubMed ID: 8315514
[TBL] [Abstract][Full Text] [Related]
11. Modulation and function of extrarenal angiotensin receptors.
Wang DH; Elijovich F
Cell Biochem Biophys; 1999; 31(1):1-17. PubMed ID: 10505665
[TBL] [Abstract][Full Text] [Related]
12. The renin-angiotensin system. New concepts in regulation of blood pressure and renal function.
Goldfarb DA
Urol Clin North Am; 1994 May; 21(2):187-94. PubMed ID: 8178386
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
Strawn WB
Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
[TBL] [Abstract][Full Text] [Related]
14. Activated and inactivated renin-angiotensin system in transgenic animals: from genes to blood pressure.
Fukamizu A; Murakami K
Lab Anim Sci; 1997 Apr; 47(2):127-31. PubMed ID: 9150489
[TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
Sandmann S; Unger T
Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
[TBL] [Abstract][Full Text] [Related]
17. The ovarian renin-angiotensin system in reproductive physiology.
Yoshimura Y
Front Neuroendocrinol; 1997 Jul; 18(3):247-91. PubMed ID: 9237079
[TBL] [Abstract][Full Text] [Related]
18. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
Haddad GE; Blackwell K; Bikhazi A
Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
[TBL] [Abstract][Full Text] [Related]
19. Second Björn Folkow Award Lecture. The renin-angiotensin system: new surprises ahead.
Schalekamp MA
J Hypertens Suppl; 1991 Dec; 9(6):S10-7. PubMed ID: 1818898
[TBL] [Abstract][Full Text] [Related]
20. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
